Back to
Trexquant Investment LP
SRPT
Showing 7 of 26 quarters
Position history for
Trexquant Investment LP's holdings in SAREPTA THERAPEUTICS INC
Yes. Trexquant Investment holds 320,349 shares of SRPT (Sarepta Therapeutics), worth $5.8M, as of its Q2 2026 13F filing. It reduced the position by 3,579 shares (-1.1%) from Q1 2026. Trexquant Investment has held SRPT since Q1 2025, across 6 quarterly 13F filings.
Current Value
$5.8M
Current Shares
320,349
Total Value Change
+$5.8M
Total Shares Change
+320,349
Quarter-by-Quarter History